Quantum Control & Pulse Engineering
72 papers from PubMed
Quantum Control & Pulse Engineering Research Context
This Quantum Articles category organizes published quantum research papers so readers can browse focused work by topic, source, and year.
Showing 25-36 of 72
Multicolor Quantum Dot Tracking Uncovers Phenotypic Rescue of DAT A559V Aberrant Diffusion Upon D2R Antagonism.
Torres R, Kovtun O, McBride JR, Bellocchio LG, Rosenthal SJ
Nerve growth factor-targeting nanocluster-antibody-drug conjugates for intravesical precision theranostics of interstitial cystitis.
Lin Z, Wang W, Liu D, Liu Q, Xu Z, Zhou X, Zhang X, Huang Y, Zhao Q, Wu Z, Yang J
Optimal trigger threshold with the bolus-tracking technique for the renal CT angiography protocol.
Asano M, Noda Y, Kawai N, Kaga T, Omata S, Takai Y, Ito A, Iwata T, Miyoshi T, Elhelaly AE, Imai H, Kato H, Matsuo M
Outcomes of patients with or without DNA repair pathway alterations: the MD Anderson IMPACT2 study.
Venturini J, Baysal MA, Chakraborty A, Yap TA, Fu S, Hong DS, Piha-Paul SA, Naing A, Ahnert JR, Dumbrava EE, Beck J, Liu Y, Kahle M, Vining DJ, Meric-Bernstam F, Tsimberidou AM
Photon-counting CT-guided bone biopsy with real-time bone marrow edema mapping.
Alvarez de Sierra Garcia B, Urtasun-Iriarte C, Nieto P, Alonso Burgos A
Polypharmacologic phosphoinositide modulation by FTY720 triggers endomembrane trafficking collapse and metabolic starvation in cancer cells.
Kofuji S, Sumita K, Ikeda Y, Takahashi Y, Tabata S, Ito D, Hirota Y, Sasaki M, Kanoh H, Nakatsu F, Takeuchi K, Senda T, Davis MI, Shen M, Wakimoto H, Hirayama A, Soga T, Simeonov A, Sasaki AT
Prospective Registry and Meta-Analysis of Particle Therapy for Hepatocellular Carcinoma: Clinical Outcomes and Real-World Impact.
Mizumoto M, Shibuya K, Terashima K, Iwata H, Saito T, Toyama S, Ogino T, Murakami M, Ohno T, Sato Y, Akimoto T, Katoh H, Wakatsuki M, Waki T, Katoh N, Koizumi F, Araya M, Onoe T, Takagi M, Okimoto T, Ogino H, Numajiri H, Shioyama Y, Hashimoto T, Ohba H, Kubo S, Hasegawa K, Maruo K, Aoyama H, Sakurai H
Quizartinib in newly diagnosed patients with FLT3-ITD-positive AML who received maintenance therapy in QuANTUM-First.
Levis MJ, Erba HP, Montesinos P, Patkowska E, Cortes JE, Perl AE, Dombret H, Amadori S, Wang J, Schlenk RF, Liu L, Mostafa Kamel Y, Imadalou K, Laadem A, Burns K, Sekeres MA
Rationale, design, and baseline characteristics of the multicENter, randomized, open-label, parallel group, study to evaluate the use of sacubitril/valsartan in HeartMate 3 left ventricular assist device recipients (ENVAD-HF).
Cikes M, Planinc I, Brugts JJ, Claggett B, Jorde UP, Milicic D, Ruschitzka F, Uriel N, Jakus N, Loncaric F, Puskaric F, Rubis P, van Laake LW, Rudez I, Hegarova M, Mehra M, Solomon SD
Risk-Based vs Annual Breast Cancer Screening: The WISDOM Randomized Clinical Trial.
Esserman LJ, Fiscalini AS, Naeim A, Van't Veer LJ, Kaster A, Scheuner MT, LaCroix AZ, Borowsky AD, Anton-Culver H, Olopade OI, Esserman J, Lancaster R, Madlensky L, Blanco AM, Ross KS, Goodman DL, Tong BS, Hogarth M, Heditsian D, Brain S, Lee V, Blum K, Kim MO, Sabacan LP, Fergus KB, Yau C, Park HL, Parker BA, Kaplan C, Rhoads KF, Eder S, Adduci K, Matthews JB, Wenger NS, Shieh Y, Hiatt RA, Ziv E, Tice JA, Eklund M
Safety and Efficacy of Aficamten in Patients With Nonobstructive Hypertrophic Cardiomyopathy: A 96-Week Analysis From FOREST-HCM.
Masri A, Sherrid MV, Choudhury L, Garcia-Pavia P, Kramer CM, Barriales-Villa R, Cooper RM, Elliott PM, Hegde SM, Maron MS, Nassif ME, Oreziak A, Owens AT, Solomon SD, Tower-Rader A, Heitner SB, Jacoby DL, Kupfer S, Malik FI, Melloni C, Simkins T, Wei J, Saberi S, FOREST-HCM Investigators
Sedation practices and associated clinical outcomes among adult ICU patients managed by advanced practice providers versus resident physicians.
Shah J, Dzierba AL, Muir J, Meier A, Peeler-Remy P, Brodie D, Yip N, Serra AL, Beitler JR